Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

Is IVL safe for patients with diabetes?
New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.
Diabetes associated with much higher risk of sudden cardiac death
According to a new study of nearly 7,000 patients, type 1 and type 2 diabetes are both linked to significantly shorter life expectancies. The risk of sudden cardiac death appears to be highest for younger patients.
FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public
The allegation came days after an internal FDA memo linked the vaccines to the deaths of multiple children. A group of former FDA commissioners pushed back against the content of that memo.
Medtronic launches new diabetes tech integrated with Abbott sensor
Two of the world's leading healthcare companies have partnered on a new treatment option for patients with type 1 diabetes.
Doctors still unsure about Trump’s heart health after ‘weird’ memo
It is still unclear which imaging exams President Donald Trump underwent to evaluate his cardiovascular health. The White House shared a memo Monday as an attempt to put this topic to bed—but questions remain.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Is IVL safe for patients with diabetes?

New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.

Diabetes associated with much higher risk of sudden cardiac death

According to a new study of nearly 7,000 patients, type 1 and type 2 diabetes are both linked to significantly shorter life expectancies. The risk of sudden cardiac death appears to be highest for younger patients.

artificial intelligence ai in healthcare

FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public

The allegation came days after an internal FDA memo linked the vaccines to the deaths of multiple children. A group of former FDA commissioners pushed back against the content of that memo.

MiniMed 780G system integrated with Instinct sensors manufactured by Abbott.

Medtronic launches new diabetes tech integrated with Abbott sensor

Two of the world's leading healthcare companies have partnered on a new treatment option for patients with type 1 diabetes.

Doctors still unsure about Trump’s heart health after ‘weird’ memo

It is still unclear which imaging exams President Donald Trump underwent to evaluate his cardiovascular health. The White House shared a memo Monday as an attempt to put this topic to bed—but questions remain.

‘Beer belly’ associated with multiple heart risks, especially in men

Abdominal obesity, the phenomenon commonly known as “beer belly," may be associated with significant risks, including heart failure. Researchers urged cardiologists and radiologists alike to keep these findings in mind going forward.

Medtronic recalls data management software, urging healthcare providers to run update

The error caused incorrect glucose data to be displayed to clinicians. According to Medtronic, any treatment decisions or recommendations based on those data need to be revisited.

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system

Abbott shares safety concerns with millions of CGM sensors—7 deaths reported

Approximately 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors need to be replaced due to a risk of incorrect glucose readings. Abbott has received reports of 736 severe adverse events and seven deaths that may be related to this issue.